2026 Agenda

Welcome Day

Thursday, 2/26/26

Poster Session & Welcome Reception

6:00 PM - 9:00 PM

Curb Conservatory & Hall of Fame Rotunda

Day One

Friday, 2/27/26

Breakfast Symposium (Non-CE)

7:30 AM - 8:20 AM

Event Hall

Managing Frail Patients with Hematologic Malignancies

Moderator: Noopur Raje, MD (Massachusetts General Hospital)
Panelists:
Reena Jayani-Kosarzycki, MD (Vanderbilt University Medical Center)
Andrew Kuykendall, MD (Moffitt Cancer Center)

Sponsored by Pfizer

Benign Hematology

Pre-Malignant Hematologic Disorders: What Do Community Providers Need to Know?

1L Standard of Care Across Lymphoid Malignancies: What's New in 2026?

1L Standard of Care Across Myeloid Malignancies: What's New in 2026?

Considerations in Treating Patients with High-Risk Hematologic Malignancies

Challenging Clinical Scenarios in the Community

Benign Hematology

Session Chair: Jennifer Green, MD (Tennessee Oncology)

CMA Theater

8:50 AM
Evolving Diagnostics in Iron Deficiency Anemia
Angela Weyand, MD (University of Michigan)

8:58 AM
The Bleeding Patient Consult
Michelle Chi, MD (Vanderbilt Health)

9:06 AM
New Developments in Sickle Cell Disease
Scott Peslak, MD, PhD (University of Pennsylvania)

9:14 AM
TTP/HUS
Spero Cataland, MD (The Ohio State University Comprehensive Cancer Center)

9:22 AM
Managing Thrombosis
Adam Cuker, MD, MS (University of Pennsylvania)

9:30 AM
Panel Discussion + Q&A

Pre-Malignant Hematologic Disorders: What Do Community Providers Need to Know?

Session Chair: Michael Byrne, DO, FACP (Greco-Hainsworth Tennessee Oncology Centers for Research)

CMA Theater

9:48 AM
MGUS/ SMM
Suzanne Lentzsch, MD, PhD (Columbia University Medical Center)

9:56 AM
CHIP/CCUS
Zhuoer Xie, MD, MS (Moffitt Cancer Center)

10:04 AM
MBL: Implications on Infectious Risk
Sameer Parikh, MBBS (Mayo Clinic)

10:12 AM
Panel Discussion + Q&A

Networking Break

10:30 AM - 11:00 AM

Grand Foyer

1L Standard of Care Across Lymphoid Malignancies: What's New in 2026?

Session Chair: Jason Chandler, MD (West Cancer Center & Research Institute​)

CMA Theater

11:00 AM
1L CLL Debate: Single Agent Monotherapy Vs Fixed Duration Combos
Adam Kittai, MD (Mount Sinai Health System)
Callie Coombs, MD (University of California Irvine) n 

11:20 AM
MM
Amrita Krishnan, MD, FACP (City of Hope)

11:28 AM
DLBCL
Ryan Lynch, MD (Fred Hutch Cancer Center)

11:36 AM
Hodgkin’s
Boyu Hu, MD (Huntsman Cancer Institute)

11:44 AM
Indolent Lymphomas
Liz Brém, MD (Univeristy of California-Irvine)

11:52 AM
Panel Discussion + Q&A

Lunch Symposium (Non-CE)

12:25 PM - 1:25 PM

Event Hall

1L Standard of Care Across Myeloid Malignancies: What's New in 2026?

Session Chair: Naveen Pemmaraju, MD (MD Anderson Cancer Center)

CMA Theater

1:40 PM
MF
John Mascarenhas, MD (Mount Sinai Health System)

1:48 PM
CML
Elias Jabbour

1:56 PM
MDS
Anthony Hunter, MD (Emory Winship Cancer Institute)

2:04 PM
MPNs
Gabriela Hobbs, MD (Massachusetts General Hospital)

2:12 PM
Panel Discussion + Q&A

Considerations in Treating Patients with High-Risk Hematologic Malignancies

Session Chair: Joshua Richter, MD, FACP (Mount Sinai Health System)

CMA Theater

2:32 PM
Defining High Risk Disease in Lymphoid Malignancies
Jeremy Abramson, MD (Harvard Medical School)

2:40 PM
HR MM: Time For A Paradigm Change?
Natalie Callander, MD (University of Wisconsin)

2:48 PM
TP53m MDS and AML
David Sallman, MD (Moffitt Cancer Center)

2:56 PM
Panel Discussion + Q&A

Networking Break

3:15 PM - 3:45 PM

Grand Foyer

Challenging Clinical Scenarios in the Community

Session Chair: Alexander Perl, MD (University of Pennsylvania)

CMA Theater

3:45 PM
Renal Insufficiency in Multiple Myeloma
Rahul Banerjee, MD, FACP (Fred Hutch Cancer Center)

3:53 PM
How To Tackle Curative Intent in Lymphoma Patients With Cardiac Comorbidities
Sarah Rutherford, MD (Weill Cornell Medicine)

4:01 PM
MDS/MPN Overlap Syndromes
Eric Padron, MD (Moffitt Cancer Center)

4:09 PM
AML: First-line Approach To Older, Fit Patients With AML (Induction vs. HMA/Ven)
Dan Pollyea, MD, MS (University of Colorado School of Medicine)
Jeffrey Lancet, MD (Moffitt Cancer Center)

4:29 PM
Panel Discussion + Q&A

Day Two

Saturday, 2/28/26

Breakfast Symposium (Non-CE)

7:30 AM - 8:20 AM

Event Hall

MRD Across Hematologic Malignancies

Non-Cellular Approaches in Treating Relapsed/Refractory Hematologic Malignancies

Cellular and T-cell Redirecting Therapies in Hematologic Malignancies

Amuse-Bouche: Myeloma at the Movies

Advancing Community Care

The Evolving Treatment Landscape Across Hematologic Malignancies: What's on the Horizon?

MRD Across Hematologic Malignancies

Session Chair: Christopher Benton, MD (Rocky Mountain Cancer Centers)

CMA Theater

8:45 AM
MRD in AML: Who, What, When, and How?
Chris Hourigan

8:53 AM
Defining The Value of uMRD in CLL
Chaitra Ujjani, MD (Fred Hutch Cancer Center)

9:01 AM
MRD in MM: How, When and Why?
Noopur Raje, MD (Massachusetts General Hospital)

9:09 AM
ctDNA in Lymphoma

9:17 AM
Debate: Is Len Until Progression Still The Optimal Maintenance in The Quad Era?
Peter Voorhees, MD (Atrium Health Levine Cancer Institute)
Faith Davies, MD (NYU Langone Health)

9:37 AM
Panel Discussion + Q&A

Non-Cellular Approaches in Treating Relapsed/Refractory Hematologic Malignancies

Session Chair: Katie Largent, DMSc, PA-C, CPAAPA (Tennessee Oncology)

CMA Theater

9:55 AM
Multiple Myeloma
Caitlin Costello, MD (University of California-San Diego)

10:03 AM
CLL
Jacqueline Barrientos, MD, MS (Mount Sinai Health System)

10:11 AM
iNHL
Krish Patel, MD (Sarah Cannon Research Institute)

10:19 AM
AML
Rami Komrokji, MD (Moffitt Cancer Center)

10:27 AM
Panel Discussion + Q&A

Networking Break

10:45 AM - 11:15 AM

Grand Foyer

Cellular and T-cell Redirecting Therapies in Hematologic Malignancies

Session Chair: Yi Lin, MD, PhD (Mayo Clinic)

CMA Theater

11:15 AM
CAR-T in MM
Krina Patel, MD, MSc (MD Anderson Cancer Center)

11:23 AM
CAR-T in NHL
Elise Chong, MD (University of Pennsylvania)

11:31 AM
Bispecifics in MM
Susan Bal, MD (University of Alabama at Birmingham)

11:39 AM
Bispecifics in NHL
Tycel Phillips, MD (City of Hope)

11:47 AM
Managing Acute Toxicities with Cellular and T-Cell Redirecting Therapies

11:55 AM
Panel Discussion + Q&A

Amuse-Bouche: Myeloma at the Movies

12:15 AM
Remember the Future
Saad Usmani

Lunch Symposium (Non-CE)

12:40 PM - 1:40 PM

Event Hall

Advancing Community Care

Session Chair: Jonathan Abbas, MD (Tennessee Oncology)

CMA Theater

1:55 PM
Utilizing Remote Consultation To Optomize Patient Care in The Community Setting
Jennifer Green, MD (Tennessee Oncology)

2:03 PM
Utilizing Frailty Indexes
Reena Jayani-Kosarzycki, MD, MSCI (Vanderbilt Health)

2:11 PM
Bringing Bispecifics to the Community
Tara Graff, DO, MS (Mission Cancer + Blood)

2:19 PM
Managing Long term toxicities with Cellular and T-Cell redirecting therapies
Adam Cohen, MD (University of Pennsylvania)

2:27 PM
Panel Discussion +Q&A

Networking Break

2:45 PM - 3:15 PM

Grand Foyer

The Evolving Treatment Landscape Across Hematologic Malignancies: What's on the Horizon?

Session Chairs??

CMA Theater

3:15 PM
MM
Ajay Nooka, MD, MPH (Emory Winship Cancer Institute)

3:23 PM
CLL
Deborah Stephens, DO (University of North Carolina School of Medicine)

3:31 PM
NHL
Ryan Jacobs, MD (Atrium Health Levine Cancer Institute)

3:39 PM
AML+MDS
Uma Borate, MBBS (The Ohio State University Comprehensive Cancer Center)

3:47 PM
MPNs +SM+CML
Kristen Pettit, MD (University of Michigan)

3:55 PM
Q&A

Keynote Speaker (Non-CE)

David Fajgenbaum, MD, MBA, MSc
Co-Founder & President of Every Cure and a Physician-Scientist at the University of Pennsylvania

AI in Hematology

4:15 PM - 5:00 PM

CMA Theatre

Farewell Reception

5:00 PM - 7:00 PM

Event Hall

*Agenda is subject to change.

Experience Nashville, TN

Come for the education.
Stay for the fun.